SIO GENE THERAPIES INC (SIOX) Stock Balance Sheet
NASDAQ:SIOX - Nasdaq - US8293991043 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 49.87M | 63.73M | 118.99M | 80.80M | 107.00M | |||
| Receivables | 355.00K | 1.61M | 6.00M | 1.70M | 1.70M | |||
| Other Current Assets | 3.52M | 6.40M | 7.35M | 3.00M | 5.90M | |||
| Total Current Assets | 53.74M | 71.74M | 132.33M | 85.40M | 114.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.00K | 3.34M | 1.63M | 2.30M | 1.30M | |||
| Investments And Advances | N/A | N/A | N/A | 5.90M | 5.90M | |||
| Other Non-Current Assets | N/A | 0.00 | 1.18M | 0.00 | 1.00M | |||
| Total Non-Current Assets | 7.00K | 3.34M | 2.81M | 8.30M | 8.10M | |||
| TOTAL ASSETS | 53.75M | 75.08M | 135.15M | 93.70M | 122.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 15.40M | 21.20M | |||
| Accrued Expenses | 2.87M | 2.90M | 2.64M | 3.40M | 3.90M | |||
| Accounts Payable | 1.96M | 3.98M | 1.34M | 4.40M | 1.70M | |||
| Other Current Liabilities | N/A | 6.12M | 6.87M | 8.80M | 16.70M | |||
| Total Current Liabilities | 4.83M | 13.00M | 10.85M | 32.00M | 43.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 0.00 | 0.00 | 0.00 | 23.00M | |||
| Other Non-Current Liabilities | 0.00 | 1.73M | 932.00K | 100.00K | N/A | |||
| Total Non-Current Liabilities | 0.00 | 1.73M | 932.00K | 100.00K | 23.00M | |||
| TOTAL LIABILITIES | 4.83M | 14.73M | 11.78M | 32.10M | 66.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -874.44M | -862.96M | -791.07M | -758.60M | -686.00M | |||
| Additional Paid In Capital | 923.02M | 922.97M | 914.10M | 820.30M | 741.30M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 331.00K | 337.00K | 335.00K | -100.00K | 900.00K | |||
| Shares Outstanding | 73.98M | 73.74M | 69.38M | 39.50M | 22.80M | |||
| Tangible Book Value per Share | 0.66 | 0.82 | 1.78 | 1.56 | 2.46 | |||
| Total Shareholders' Equity | 48.91M | 60.35M | 123.37M | 61.60M | 56.20M | |||
| TOTAL LIABILITIES AND EQUITY | 53.75M | 75.08M | 135.15M | 93.70M | 122.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.41 | |||
| Current Ratio | 11.12 | 5.52 | 12.20 | 2.67 | 2.63 | |||
| Return On Assets (ROA) | -93.53% | -95.75% | -23.99% | -77.51% | -105.19% | |||
| Return On Equity (ROE) | -102.77% | -119.12% | -26.28% | -117.91% | -229.66% | |||
All data in USD , ROIC based on taxRate of 0.21